Page 1 of 1

Kelun BiotechB K: AntiPDL tagolizumab approved for marketing by the National Medical Products Administration

Posted: Tue Feb 18, 2025 6:41 am
by Rina7RS
HiSun ​​Technology K Profit Warning: Expected Operating Profit to Decrease Significantly or Even to Incur Operating Loss in

Medical Innovation


Acquisition and sale

China Greenland Broad Green K plans to acquire equity in a company that provides operation and maintenance services for hydropower stations to enter the new energy sector

Zhongda Group Holdings K plans to acquire equity of Chinese Asset switzerland phone number list Management for HK$ million

Weihong Group Holdings K seeks new business opportunities and intends to acquire a controlling stake in a company

Equity Incentive

KEW K granted a total of . million restricted share units

Rights issue

GBA Group K plans to place up to million shares at a discount of . to raise a net amount of HK$. million

Repurchase and cancellation

Tencent Holdings K spent HK$ million to repurchase . million shares on December

AlibabaW K spent US$. million to repurchase . million shares on December

ShellW K spent US$ million to repurchase . million shares on December

AIA K spent HK$. million to repurchase . million shares on December.